Log in to search using one of your social media accounts:

 

Advanced PET imaging in oncology: status and developments with current and future relevance to lung cancer care

Purpose of review This review highlights the status and developments of PET imaging in oncology, with particular emphasis on lung cancer. We discuss the significance of PET for diagnosis, staging, decision-making, monitoring of treatment response, and drug development. The PET key advantage, the noninvasive assessment of functional and molecular tumor characteristics including tumor heterogeneity, as well as PET trends relevant to cancer care are exemplified. Recent findings Advances of PET and radiotracer technology are encouraging for multiple fields of oncological research and clinical application, including in-depth assessment of PET images by texture analysis (radiomics). Whole body PET imaging and novel PET tracers allow assessing characteristics of most types of cancer. However, only few PET tracers in addition to 18F-fluorodeoxyglucose have sufficiently been validated, approved, and are reimbursed for a limited number of indications. Therefore, validation and standardization of PET parameters including tracer dosage, image acquisition, post processing, and reading are required to expand PET imaging as clinically applicable approach. Summary Considering the potential of PET imaging for precision medicine and drug development in lung and other types of cancer, increasing efforts are warranted to standardize PET technology and to provide evidence for PET imaging as a guiding biomarker in nearly all areas of cancer treatment.
Source: Current Opinion in Oncology - Category: Cancer & Oncology Tags: LUNG AND MEDIASTINUM: Edited by Robert Pirker Source Type: research

Related Links:

Following cancer treatment, it is important to support and enable an increasing number of cancer survivors to live as healthy a life as possible for as long as possible. In this interview, Pamela Rose... Author: VJOncology Added: 02/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Following the promising results of initial investigations into the use of an electronic healthcare assessment tool in the delivery of supportive care to lung cancer patients, the tool is going to cont... Author: VJOncology Added: 02/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Integrating technology into healthcare service delivery can improve patient experience whilst improving efficiency. In this interview, Pamela Rose, Macmillan Lung Cancer Clinical Nurse Specialist, of ... Author: VJOncology Added: 02/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
As lung cancer screening is a relatively new area, particularly to non-healthcare professionals, understanding of the procedure and risks involved are generally not well understood. Here, Mamta Rupare... Author: VJOncology Added: 02/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
CONCLUSIONS: The expression of SPOCK1 served as a tumor promoter, possibly through the Wnt/β-catenin signaling pathway in NSCLC. Targeting SPOCK1 could be a potential therapeutic strategy in NSCLC. PMID: 29461591 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Abstract Primary lung cancer is the most frequent cause of cancer-related deaths worldwide. Cisplatin has been used as a key drug in the treatment for patients with lung cancer; however, most of the patients failed to respond to cisplatin within several months, and the mechanisms underlying the cisplatin resistance have not been fully elucidated. Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is a key adaptor protein in the formation of inflammasomes. ASC is also involved in apoptotic signaling. Importantly, ASC expression is decreased in lung cancer and various cancers, but ...
Source: The Tohoku Journal of Experimental Medicine - Category: Research Authors: Tags: Tohoku J Exp Med Source Type: research
Publication date: Available online 21 February 2018 Source:Journal of Orthopaedics Author(s): Bassel G. Diebo, Denis Cherkalin, Cyrus M. Jalai, Neil V. Shah, Greg W. Poorman, George A. Beyer, Frank A. Segreto, Virginie Lafage, Qais Naziri, Jared M. Newman, William P. Urban, Thomas J. Errico, Frank J. Schwab, Carl B. Paulino, Peter G. Passias Retrospective review of National Inpatient Sample (2000-2012) revealed that 31.28% of musculoskeletal (MSK) patients were found to have in-hospital psychological burdens (PBs). Adult spinal deformity (ASD), degenerative disc disease (DDD) and lung cancer patients had highest PB-preval...
Source: Journal of Orthopaedics - Category: Orthopaedics Source Type: research
Abstract AimsGATA6 is known to play a role in lung development. However, its role in the carcinogenesis of lung cancer is not well studied. The aim of this study was to analyze GATA6 expression in lung adenocarcinomas (LA) by immunohistochemistry (IHC) to define its association with clinicopathological characteristics. Methods and resultsIHC analysis of GATA6 was performed using tissue microarray slides containing 348 LAs. The association between GATA6 expression and clinicopathological parameters was evaluated. GATA6 expression in epithelial tumors other than lung cancer was also evaluated. GATA6‐positivity occurred in ...
Source: Histopathology - Category: Pathology Authors: Tags: Original Article Source Type: research
Lung cancer is a malignant tumor with the highest incidence and mortality around the world. Recent advances in RNA sequencing technology have enabled insights into long non-coding RNAs (lncRNAs), a previously ...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Tags: Primary Research Source Type: research
AbstractThe diagnosis of leptomeningeal metastases (LM) of solid tumors is complicated due to low sensitivities of both magnetic resonance imaging (MRI) and cytology. MRI has a sensitivity of 76% for the diagnosis of LM and cerebrospinal fluid (CSF) cytology has a sensitivity of 44 –67% at first lumbar puncture which increases to 84–91% upon second CSF sampling. Epithelial cell adhesion molecule (EpCAM) is expressed by solid tumors of epithelial origin like non-small-cell lung cancer, breast cancer or ovarium cancer. Recently, a CELLSEARCH® assay and flow cytometry laboratory techniques have been developed ...
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Mergers and Aquisitions